Skip to main content

Press Releases

Image
hesai
February 2, 2024

Today, Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party (CCP) issued the following statement regarding the Department of Defense’s (DoD) recent inclusion of more than a dozen new People’s Republic of China (PRC) companies – including PRC LiDAR maker He

Issues: Defense

Image
cranes
February 1, 2024

WASHINGTON, D.C. — Today, Chairman Mike Gallagher (R-WI), Ranking Member Krishnamoorthi (D-IL), and Rep. Dusty Johnson (R-SD) of the House Select Committee on the Chinese Communist Party and Chairman Sam Graves (R-MO), Ranking Member Rick Larsen (D-WA), and Rep.


Image
Gallagher
February 1, 2024

WASHINGTON, D.C.-- Last evening, Rep. Mike Gallagher (R-WI), Chairman of the Select Committee on the Chinese Communist Party, addressed religious leaders in a keynote speech at the National Prayer Breakfast Gathering.


Image
Cyber Hearing
January 31, 2024

WASHINGTON, D.C.- This morning, Rep. Mike Gallagher (R-WI) and Rep.


Image
cyber
January 31, 2024

WASHINGTON, D.C.-- Today, the Select Committee on the Chinese Communist Party is holding a hearing titled, "The CCP Cyber Threat to the American Homeland and National Security."


Image
authoritarian alignment
January 30, 2024

WASHINGTON, D.C.-- Today, the Select Committee on the Chinese Communist Party is holding a hearing titled, "Authoritarian Alignment: The CCP's Support for America's Adversaries." 


Image
Ford CATL
January 29, 2024

As part of their ongoing investigation into Ford Motor Company’s partnership with China-based EV battery maker Contemporary Amperex Technology Co.


Image
BGI import
January 25, 2024

WASHINGTON, D.C. — Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition between the United States and the Chinese Communist Party today introduced the BIOSECURE Act, a bill to ensure foreign adversary biotech companies of U.S. national security concern do not gain access to U.S. taxpayer dollars.

Issues: Biosecurity